A Novel Therapeutic Combination to Overcome Doxorubicin-Induced Cardiotoxicity Using HO-3867 for the Treatment of Multi-drug Resistant Breast Cancer

被引：0
|
作者：
Dayton, Alex [1 ]
Selvendiran, Karuppaiyah [1 ]
Kalai, Tamas [2 ]
Hideg, Kalman [2 ]
Kuppusamy, Periannan [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Univ Pecs, Pecs, Hungary
来源：
FREE RADICAL BIOLOGY AND MEDICINE | 2010年 / 49卷
关键词：
D O I：
10.1016/j.freeradbiomed.2010.10.131
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S57 / S58
页数：2
相关论文
共 13 条
  • [1] Amelioration of Doxorubicin-Induced Cardiotoxicity by an Anticancer-Antioxidant Dual-Function Compound, HO-3867
    Dayton, Alex
    Selvendiran, Karuppaiyah
    Meduru, Sarath
    Khan, Mahmood
    Kuppusamy, M. Lakshmi
    Naidu, Shan
    Kalai, Tamas
    Hideg, Kalman
    Kuppusamy, Periannan
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 339 (02): : 350 - 357
  • [2] A novel chitosan-based nanomedicine for multi-drug resistant breast cancer therapy
    Niu, Shiwei
    Williams, Gareth R.
    Wu, Jianrong
    Wu, Junzi
    Zhang, Xuejing
    Zheng, Hong
    Li, Shude
    Zhu, Li-Min
    CHEMICAL ENGINEERING JOURNAL, 2019, 369 : 134 - 149
  • [3] Hypoxia-mediated activation of signal transducer and activator of transcription 3 (STAT3) in ovarian cancer: A novel therapeutic strategy using HO-3867, a STAT3 inhibitor
    McCann, G.
    Selvendiran, K.
    Hideg, K.
    Cohn, D.
    Kuppusamy, P.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S25 - S25
  • [4] Tumor targeted combination therapeutic system for the effective treatment of drug resistant triple negative breast cancer
    Cai, Zedong
    Huan, Meng-Lei
    Zhang, Yao-Wen
    Zhao, Ting-Ting
    Han, Tian-Yan
    He, Wei
    Zhou, Si-Yuan
    Zhang, Bang-Le
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 636
  • [5] Therapeutic Efficacy and Safety of Paclitaxel/Lonidamine Loaded EGFR-Targeted Nanoparticles for the Treatment of Multi-Drug Resistant Cancer
    Milane, Lara
    Duan, Zhenfeng
    Amiji, Mansoor
    PLOS ONE, 2011, 6 (09):
  • [6] Targeting CAR and Nrf2 improves cyclophosphamide bioactivation while reducing doxorubicin-induced cardiotoxicity in triple-negative breast cancer treatment
    Stern, Sydney
    Liang, Dongdong
    Li, Linhao
    Kurian, Ritika
    Lynch, Caitlin
    Sakamuru, Srilatha
    Heyward, Scott
    Zhang, Junran
    Kareem, Kafayat Ajoke
    Chun, Young Wook
    Huang, Ruili
    Xia, Menghang
    Hong, Charles C.
    Xue, Fengtian
    Wang, Hongbing
    JCI INSIGHT, 2022, 7 (12)
  • [7] MicroRNA-4732-3p Is Dysregulated in Breast Cancer Patients with Cardiotoxicity, and Its Therapeutic Delivery Protects the Heart from Doxorubicin-Induced Oxidative Stress in Rats
    Sanchez-Sanchez, Rafael
    Reinal, Ignacio
    Peiro-Molina, Esteban
    Buigues, Marc
    Tejedor, Sandra
    Hernandiz, Amparo
    Selva, Marta
    Hervas, David
    Canada, Antonio J.
    Dorronsoro, Akaitz
    Santaballa, Ana
    Salvador, Carmen
    Caiment, Florian
    Kleinjans, Jos
    Martinez-Dolz, Luis
    Moscoso, Isabel
    Lage, Ricardo
    Gonzalez-Juanatey, Jose R.
    Panadero, Joaquin
    Aparicio-Puerta, Ernesto
    Bernad, Antonio
    Sepulveda, Pilar
    ANTIOXIDANTS, 2022, 11 (10)
  • [8] O2-evolving and ROS-activable nanoparticles for treatment of multi-drug resistant Cancer by combination of photodynamic therapy and chemotherapy
    Luo, Zhijian
    Li, Mingxing
    Zhou, Meiling
    Li, Huayun
    Chen, Youyou
    Ren, Xiaoqun
    Dai, Yan
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2019, 19 : 49 - 57
  • [9] Nanoparticle delivery of a pH-sensitive prodrug of doxorubicin and a mitochondrial targeting VES-H8R8 synergistically kill multi-drug resistant breast cancer cells
    Czupiel, Petro
    Delplace, Vianney
    Shoichet, Molly
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [10] Nanoparticle delivery of a pH-sensitive prodrug of doxorubicin and a mitochondrial targeting VES-H8R8 synergistically kill multi-drug resistant breast cancer cells
    Petro Czupiel
    Vianney Delplace
    Molly Shoichet
    Scientific Reports, 10
12